We are live on ! Find out more
DHFB

Dixon Hubard Feinour & Brown Portfolio holdings

AUM $842M
1-Year Est. Return 2.74%
This Fund
S&P 500
This Quarter Est. Return
-2.33%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
AUM
$999M
AUM Growth
-$39.8M
Cap. Flow
+$13M
Cap. Flow %
1.3%
Top 10 Hldgs %
23.26%
Holding
320
New
23
Increased
117
Reduced
113
Closed
13

Top Sells

Rank Stock Value
1
ALB icon
Albemarle
ALB
+$10.3M
2
TRMB icon
Trimble
TRMB
+$8.57M
3
TMO icon
Thermo Fisher Scientific
TMO
+$7.61M
4
DG icon
Dollar General
DG
+$5.39M
5
EL icon
Estee Lauder
EL
+$4.77M

Sector Composition

Rank Sector Weight
1 Technology 19.45%
2 Healthcare 12.15%
3 Financials 10.27%
4 Consumer Staples 6.19%
5 Industrials 6.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COST icon
26
Costco
COST
$420B
$11.5M 1.15%
19,905
-1,847
-8% -$969K
TXN icon
27
Texas Instruments
TXN
$261B
$11.3M 1.13%
61,351
-2,235
-4% -$394K
SEDG icon
28
SolarEdge
SEDG
$1.95B
$10.9M 1.09%
33,748
+2,043
+6% +$561K
CVS icon
29
CVS Health
CVS
$122B
$10.8M 1.08%
106,577
+1,417
+1% +$149K
JNJ icon
30
Johnson & Johnson
JNJ
$625B
$10.4M 1.05%
58,935
-2,570
-4% -$437K
CP icon
31
Canadian Pacific Kansas City
CP
$80.5B
$10.1M 1.01%
122,571
+3,025
+3% +$228K
ORI icon
32
Old Republic International
ORI
$10.4B
$9.91M 0.99%
+383,256
New +$9.89M
ABT icon
33
Abbott
ABT
$187B
$9.7M 0.97%
81,915
-577
-0.7% -$71.5K
TMO icon
34
Thermo Fisher Scientific
TMO
$220B
$9.67M 0.97%
16,366
-13,254
-45% -$7.61M
VDE icon
35
Vanguard Energy ETF
VDE
$9.84B
$9.19M 0.92%
+85,836
New +$8.26M
SPYM
36
State Street SPDR Portfolio S&P 500 ETF
SPYM
$169B
$8.85M 0.89%
166,569
-13,380
-7% -$701K
KBE icon
37
State Street SPDR S&P Bank ETF
KBE
$1.71B
$8.76M 0.88%
167,307
-242
-0.1% -$13.5K
XOM icon
38
ExxonMobil
XOM
$634B
$7.8M 0.78%
94,434
+6,990
+8% +$543K
CBOE icon
39
Cboe Global Markets
CBOE
$29.9B
$7.69M 0.77%
67,171
-300
-0.4% -$35.5K
PEP icon
40
PepsiCo
PEP
$190B
$7.2M 0.72%
43,010
-901
-2% -$151K
QCOM icon
41
Qualcomm
QCOM
$176B
$7.19M 0.72%
47,031
-2,378
-5% -$399K
CRM icon
42
Salesforce
CRM
$158B
$6.86M 0.69%
32,294
-383
-1% -$82.4K
DIS icon
43
Walt Disney
DIS
$181B
$6.75M 0.68%
49,200
+488
+1% +$70.5K
PG icon
44
Procter & Gamble
PG
$339B
$6.57M 0.66%
42,966
+412
+1% +$64.5K
PFE icon
45
Pfizer
PFE
$153B
$6.35M 0.64%
122,678
+7,536
+7% +$391K
MRK icon
46
Merck
MRK
$318B
$6.05M 0.61%
73,765
+624
+0.9% +$49.2K
ELV icon
47
Elevance Health
ELV
$85.5B
$5.97M 0.6%
12,158
+250
+2% +$114K
DG icon
48
Dollar General
DG
$27.9B
$5.96M 0.6%
26,780
-25,370
-49% -$5.39M
LLY icon
49
Eli Lilly
LLY
$1.06T
$5.64M 0.56%
19,698
-85
-0.4% -$21.9K
VZ icon
50
Verizon
VZ
$196B
$5.62M 0.56%
110,235
+2,664
+2% +$141K

Similar funds

Dixon Hubard Feinour & Brown's Q1 2022 Portfolio in Review

As of Q1 2022, Dixon Hubard Feinour & Brown held 320 positions worth $999M, down 3.8% from $1.04B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Dixon Hubard Feinour & Brown's Q1 2022 filing shows 23 new, 117 increased, 113 reduced and 13 closed positions. Its largest new stake was Old Republic International: 383,256 shares worth $9.91M. The largest sale was Albemarle, an estimated $10.3M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

  • Dixon Hubard Feinour & Brown's largest Q1 2022 buy was Old Republic International: 383,256 shares worth $9.91M.
  • Dixon Hubard Feinour & Brown added most to Williams Companies in Q1 2022, an estimated $11.2M increase.
  • Dixon Hubard Feinour & Brown's biggest Q1 2022 reduction was Thermo Fisher Scientific, cutting an estimated $7.61M.
  • Dixon Hubard Feinour & Brown fully exited Albemarle in Q1 2022, selling an estimated $10.3M.
  • Dixon Hubard Feinour & Brown's ten largest holdings make up 23% of its $999M portfolio in Q1 2022.
  • Dixon Hubard Feinour & Brown opened 23 new positions and closed 13 in Q1 2022.
  • Dixon Hubard Feinour & Brown's portfolio value fell 3.8% quarter-over-quarter to $999M.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q1 2022, filed 9 May 2022.